The beauty supply chain faces consolidation, restructuring and investment as BASF, Evonik, Solabia, Symrise and Cosmax navigate manufacturing and ingredient innovation.

THE WHAT? The US Food and Drug Administration (FDA) has cleared Lynch Regenerative Medicine’s Investigational New Drug application for a Phase 2 clinical trial evaluating injectable recombinant human ...

Indonesia has extended certain halal certification deadlines to 2028, giving cosmetics and personal care manufacturers more ...

Richard Ridinger as Chairman of the Board, succeeding Thomas Leysen and strengthening leadership across fragrance, personal ...

Solabia is restructuring its business around cosmetics and nutraceutical ingredients, appointing former NUXE CEO Muriel Koch ...

Unilever has agreed to sell its Welly first-aid brand to Forward Consumer Partners as it continues reshaping its portfolio ...

L’Oréal has appointed North Asia CFO Pietro Andrea Brambilla to the boards of two major Chinese cosmetics manufacturing subsidiaries, strengthening regional governance.

Proya Cosmetics has opened a new innovation laboratory in France to strengthen international research partnerships and ...

Beauty Edit concept into 48 Sephora stores across Southeast Asia and Hong Kong, creating new distribution opportunities for ...

Bluemercury has relaunched its proprietary makeup brand Lune+Aster with a refreshed identity and expanded assortment to ...

Bogart has sold its 47-store Israeli cosmetics retail subsidiary for €5.8 million as part of a broader restructuring of its ...

An unofficial AI-generated concept combining Hunter boots and Rhode cosmetics highlights the risks of synthetic imagery for ...